LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Bradykinin antagonist quinolines

Utility Patent

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Bradykinin antagonist quinolines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists

Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from roseaceae

Bradykinin antagonists comprising rosaceae plant extracts

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists containing pentafluorophenylalanine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists for the prophylaxis or treatment of virus

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin antagonists with extended hydrophobic side chains

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin B 2 receptor antagonist peptide from amphibian skin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Bradykinin B1 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin peptides with modifications at the N terminus

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Bradykinin receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin receptor antagonists with neurokinin receptor blockin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Bradykinin type peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Bradykinin-B1 antagonists, process for their preparation and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...

Bradykinin-inhibiting tripeptide derivatives

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Bradyrhizobium japonicum nodulation inducing factor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

BRAF mutation T1796A in thyroid cancers